These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 15188365

  • 21. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S, Trick D, Sondermann P, Kamino K, Schlegelberger B, Kniesch K, Tiede A, Jacob U, Schmidt RE, Witte T.
    Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
    [Abstract] [Full Text] [Related]

  • 22. Treatment of autoimmune MRL/Ipr mice with monoclonal antibody to Thy-1.2: a single injection has sustained effects on lymphoproliferation and renal disease.
    Seaman WE, Wofsy D, Greenspan JS, Ledbetter JA.
    J Immunol; 1983 Apr; 130(4):1713-8. PubMed ID: 6187819
    [Abstract] [Full Text] [Related]

  • 23. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J, Rupanagudi KV, Kulkarni OP, Darisipudi MN, Allam R, Anders HJ.
    J Immunol; 2011 Sep 15; 187(6):3413-21. PubMed ID: 21849682
    [Abstract] [Full Text] [Related]

  • 24. OBF-1 is essential for the generation of antibody-secreting cells and the development of autoimmunity in MRL-lpr mice.
    Zuo J, Ge H, Zhu G, Matthias P, Sun J.
    J Autoimmun; 2007 Sep 15; 29(2-3):87-96. PubMed ID: 17574818
    [Abstract] [Full Text] [Related]

  • 25. A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice.
    Chan O, Shlomchik MJ.
    J Immunol; 1998 Jan 01; 160(1):51-9. PubMed ID: 9551955
    [Abstract] [Full Text] [Related]

  • 26. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S, Nakano S, Watanabe T, Tamayama Y, Mitsuo A, Nakiri Y, Suzuki J, Nozawa K, Amano H, Tokano Y, Kobata T, Takasaki Y.
    Rheumatology (Oxford); 2007 Jul 01; 46(7):1083-6. PubMed ID: 17500077
    [Abstract] [Full Text] [Related]

  • 27. B cell genotype determines the fine specificity of autoantibody in lpr mice.
    Kakkanaiah VN, Sobel ES, MacDonald GC, Cheek RL, Cohen PL, Eisenberg RA.
    J Immunol; 1997 Jul 15; 159(2):1027-35. PubMed ID: 9218626
    [Abstract] [Full Text] [Related]

  • 28. Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide.
    Ferrera F, Hahn BH, Rizzi M, Anderson M, Fitzgerald J, Millo E, Indiveri F, Shi FD, Filaci G, La Cava A.
    Arthritis Rheum; 2007 Jun 15; 56(6):1945-53. PubMed ID: 17530718
    [Abstract] [Full Text] [Related]

  • 29. Terminal deoxynucleotidyl transferase deficiency reduces the incidence of autoimmune nephritis in (New Zealand Black x New Zealand White)F1 mice.
    Conde C, Weller S, Gilfillan S, Marcellin L, Martin T, Pasquali JL.
    J Immunol; 1998 Dec 15; 161(12):7023-30. PubMed ID: 9862739
    [Abstract] [Full Text] [Related]

  • 30. IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/Ipr mice.
    Haas C, Ryffel B, Le Hir M.
    J Immunol; 1997 Jun 01; 158(11):5484-91. PubMed ID: 9164971
    [Abstract] [Full Text] [Related]

  • 31. Role of the costimulatory molecule CD28 in the development of lupus in MRL/lpr mice.
    Tada Y, Nagasawa K, Ho A, Morito F, Koarada S, Ushiyama O, Suzuki N, Ohta A, Mak TW.
    J Immunol; 1999 Sep 15; 163(6):3153-9. PubMed ID: 10477582
    [Abstract] [Full Text] [Related]

  • 32. BAFF overexpression and accelerated glomerular disease in mice with an incomplete genetic predisposition to systemic lupus erythematosus.
    Stohl W, Xu D, Kim KS, Koss MN, Jorgensen TN, Deocharan B, Metzger TE, Bixler SA, Hong YS, Ambrose CM, Mackay F, Morel L, Putterman C, Kotzin BL, Kalled SL.
    Arthritis Rheum; 2005 Jul 15; 52(7):2080-91. PubMed ID: 15986357
    [Abstract] [Full Text] [Related]

  • 33. Lupus nephritis reoccurs following transplantation in the lupus prone mouse.
    Hamar P, Wang M, Godo M, Kokeny G, Rosivall L, Ouyang N, Heemann U.
    Lupus; 2010 Feb 15; 19(2):175-81. PubMed ID: 19946036
    [Abstract] [Full Text] [Related]

  • 34. Antigen-specific therapy of murine lupus nephritis using nucleosomal peptides: tolerance spreading impairs pathogenic function of autoimmune T and B cells.
    Kaliyaperumal A, Michaels MA, Datta SK.
    J Immunol; 1999 May 15; 162(10):5775-83. PubMed ID: 10229810
    [Abstract] [Full Text] [Related]

  • 35. Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice.
    Takahashi K, Kozono Y, Waldschmidt TJ, Berthiaume D, Quigg RJ, Baron A, Holers VM.
    J Immunol; 1997 Aug 01; 159(3):1557-69. PubMed ID: 9233655
    [Abstract] [Full Text] [Related]

  • 36. Autoantibody production is associated with polyclonal B cell activation in autoimmune mice which express the lpr or gld genes.
    Ishigatsubo Y, Steinberg AD, Klinman DM.
    Eur J Immunol; 1988 Jul 01; 18(7):1089-93. PubMed ID: 3261246
    [Abstract] [Full Text] [Related]

  • 37. Serum soluble MD-1 levels increase with disease progression in autoimmune prone MRL(lpr/lpr) mice.
    Sasaki S, Nagai Y, Yanagibashi T, Watanabe Y, Ikutani M, Kariyone A, Tsuneyama K, Hirai Y, Takatsu K.
    Mol Immunol; 2012 Jan 01; 49(4):611-20. PubMed ID: 22118968
    [Abstract] [Full Text] [Related]

  • 38. Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice.
    Hasegawa H, Kohno M, Sasaki M, Inoue A, Ito MR, Terada M, Hieshima K, Maruyama H, Miyazaki J, Yoshie O, Nose M, Fujita S.
    Arthritis Rheum; 2003 Sep 01; 48(9):2555-66. PubMed ID: 13130475
    [Abstract] [Full Text] [Related]

  • 39. Vaccination with autoreactive CD4(+)Th1 clones in lupus-prone MRL/Mp-Fas(lpr/lpr) mice.
    Fujii T, Okada M, Fujita Y, Sato T, Tanaka M, Usui T, Umehara H, Mimori T.
    J Autoimmun; 2009 Sep 01; 33(2):125-34. PubMed ID: 19596182
    [Abstract] [Full Text] [Related]

  • 40. Persistence of autoreactive T cell drive is required to elicit anti-chromatin antibodies in a murine model of drug-induced lupus.
    Kretz-Rommel A, Rubin RL.
    J Immunol; 1999 Jan 15; 162(2):813-20. PubMed ID: 9916703
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.